Jeanne Menez-Jamet

Qualyst Transporter Solutions LLC provides hepatic drug transporter products and contract research services utilizing the patented B-CLEAR technology. The company was founded by Kenneth R. Brouwer, Gary M. Pollack and Dhiren R. Thakker in 2001 and is headquartered Durham, NC.

Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

ATANIS Biotech AG is a company based in Oberkirch, Germany that provides a functional allergy diagnostic screening test. The German company's mission is to revolutionize the way allergies are diagnosed and improve treatment success. The company is driven by scientific excellence and provide a proprietary mast cell line that functions as an ex vivo alternative to in vivo testing. Noemi Bachmeier-Zbären, Jean-Pierre Kinet has been the CEOs since 2021. The company was founded in 2021 by Alexander Eggel, Thomas Kaufmann, Noemi Bachmeier-Zbären, Jean-Pierre Kinet.

iXCore deals with marine, aeronautics, and fund industries. It offers in maritime, land and space industry, biotechnology, and investment. The company was founded on September 21, 2001 and is headquartered in Marly-le-Roi, IF.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

iXBlue SAS manufactures navigation systems using high-spec fiber-optic gyroscopes. The firm offers surface gyrocompasses, photonic components and modules, motion simulators, stabilized platforms, testing and calibration tables, optical fibers and modulators, surface and unmanned underwater vehicle navigators, and space sensors. The company was founded on September 27, 2000 and is headquartered in Saint-Germain-en-Laye, France.

Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France.

Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France.

Part of UCB SA, UCB Pharma SA (France) specializes in allergic and respiratory diseases and disorders. The company is based in Nanterre, France.

Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA.

BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium.

National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.

Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital.